Key terms
About DNA
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DNA news
Apr 16
7:08am ET
Ginkgo Bioworks’ ALE technology adopted by Il Granaio delle Idee baker supplier
Apr 14
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Apr 11
7:02am ET
Ginkgo Bioworks acquires AgBiome’s platform assets, terms not disclosed
Apr 08
7:11am ET
Ginkgo Bioworks, IdeeLab Biotechnology enter agreement
Apr 03
7:07am ET
Ginkgo Bioworks, Prozomix announce new partnership
Apr 02
7:10am ET
Ginkgo Bioworks acquires Modulus Therapeutics’ cell therapy platform assets
Mar 28
8:46am ET
Largest borrow rate increases among liquid names
Mar 28
7:05am ET
Ginkgo Bioworks awarded $6M contract from DARPA
Mar 27
7:03am ET
Ginkgo Bioworks and AQUA Cultured Food announce partnership
Mar 20
8:46am ET
Largest borrow rate increases among liquid names
Mar 19
8:45am ET
Largest borrow rate increases among liquid names
Mar 13
5:35am ET
ProteoNic Biosciences announces pact with Ginkgo Bioworks
Mar 12
8:45am ET
Largest borrow rate increases among liquid names
Mar 12
7:18am ET
Ginkgo Bioworks, CDC, Xwell expand Traveler-based Genomic Surveillance program
Mar 05
3:11am ET
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)
Mar 04
8:05pm ET
Cathie Wood’s ARK Investment bought 5.8M shares of Ginkgo Bioworks today
Mar 01
7:07am ET
Ginkgo Bioworks price target lowered to $3 from $7 at TD Cowen
Feb 29
11:45pm ET
Buy Rating Affirmed for Ginkgo Bioworks Amidst Strategic Growth and Diversification
Feb 29
5:03pm ET
Ginkgo Bioworks sees FY24 revenue $215M-$235M, consensus $279.55M
Feb 29
5:02pm ET
Ginkgo Bioworks reports Q4 EPS (11c), consensus (10c)
Feb 29
2:49pm ET
Ginkgo Bioworks options imply 16.0% move in share price post-earnings
Feb 28
7:18am ET
Ginkgo Bioworks acquires Proof Diagnostics, no terms disclosed
Feb 28
7:17am ET
Ginkgo Bioworks acquires Patch Biosciences, no terms disclosed
Feb 28
7:16am ET
Ginkgo Bioworks acquires key assets of Reverie Labs, no terms
Feb 22
8:04pm ET
Cathie Wood’s ARK Investment bought 2.46M shares of Ginkgo Bioworks today
Feb 15
7:19am ET
Ginkgo Bioworks and Agenus subsidiary awarded MCDC vaccine contract
Jan 25
8:26pm ET
Cathie Wood’s ARK Investment bought 711K shares of Ginkgo Bioworks today
Jan 24
8:07pm ET
Cathie Wood’s ARK Investment bought 511K shares of Ginkgo Bioworks today
Jan 23
8:05pm ET
Cathie Wood’s ARK Investment bought 119K shares of Ginkgo Bioworks today
Jan 18
9:26pm ET
Cathie Wood’s ARK Investment bought 129K shares of Ginkgo Bioworks today
Jan 17
8:08pm ET
Cathie Wood’s ARK Investment bought 886K shares of Ginkgo Bioworks today
DNA Financials
Key terms
Ad Feedback
DNA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DNA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
